Tag: IGM Biosciences
IGM Biosciences Announces Expansion of IgM Platform into Infectious Diseases, Publication...
MOUNTAIN VIEW, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS) a clinical-stage biotechnology company focused on creating...
IGM Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results...
– Recommended Phase 2 Dose for IGM-2323 Expected in 2021 – – Initial Data from Phase 1 Trial of IGM-8444 in Solid...